Dr. Jin-hong Park Radiation Oncology
Consultant - Radiation Oncologist , Experience:
Book AppointmentAbout Doctor
Dr. Jin-hong Park is among the top radiation oncologist in Seoul, South Korea.
- Dr. Jin-hong Park education
-
- Doctor of Medicine : University of Ulsan
- Master of Medicine : University of Ulsan
- Bachelor of Medicine : Chonbuk National University
- Dr. Jin-hong Park professional experiences
-
- Assist Professor in Radiation Oncology, UUCM AMC
- Fellowship in Radiation Oncology, UUCM AMC
- Public Health Doctor
- Residency in Radiation Oncology, UUCM AMC
- Internship in UUCM AMC
Hospital
Asan Medical Centre, Seoul, South Korea
Specialization
- Cyber Knife,
- Rectal & Gastrointestinal Cancer,
- Palliative Radiotherapy,
- Brain Tumor
- Esophageal cancer
Procedures Performed
- Cyber knife treatment
- Rectal cancer radiotherapy
- Brain tumor radiotherapy
- Esophageal cancer radiotherapy
Research & Publications
| Evaluation of delivered dose to a moving target by 4D dose reconstruction in gated volumetric modulated arc therapy |
| Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma |
| Efficacy and safety of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: improved efficacy compared with gemcitabine-based regimen |
| Efficacy and safety of ultrasound-guided implantation of fiducial markers in the liver for stereotactic body radiation therapy. |
| Impact of a Multidisciplinary Team Approach for Managing Advanced and Recurrent Colorectal Cancer. |
| Local Control Outcomes Using Stereotactic Body Radiation Therapy for Liver Metastases From Colorectal Cancer. |
| Postoperative Radiotherapy for Pancreatic Cancer with Microscopically-positive Resection Margin. |
| Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer Only. |
| Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients. |
| Refining prognostic stratification of human papillomavirus-related oropharyngeal squamous cell carcinoma: different prognosis between T1 and T2. |
| Role of fractionated radiotherapy in patients with hemangioma of the cavernous sinus. |
| Total Mesorectal Excision Versus Local Excision After Favorable Response to Preoperative Chemoradiotherapy in “Early” Clinical T3 Rectal Cancer: A Propensity Score Analysis. |
| Gated Volumetric-Modulated Arc Therapy vs. Tumor-Tracking CyberKnife Radiotherapy as Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Dosimetric Comparison Study Focused on the Impact of Respiratory Motion Managements. |
| Liver Transplantation After Transarterial Chemoembolization and Radiotherapy for Hepatocellular Carcinoma with Vascular Invasion. |
| Preoperative chemoradiotherapy followed by local excision in clinical T2N0 rectal cancer. |
| Prevalence and clinical significance of cellular and acellular mucin in patients with locally advanced mucinous rectal cancer who underwent preoperative chemoradiotherapy followed by radical surgery. |
| Protective effect of ��-lipoic acid against radiation-induced fibrosis in mice. |
| Alpha-fetoprotein normalization as a prognostic surrogate in small hepatocellular carcinoma after stereotactic body radiotherapy: a propensity score matching analysis. |
| Effectiveness of adjuvant radiotherapy after local excision of rectal cancer with deep submucosal invasion: a single-hospital, case-control analysis |
| Influence of Preoperative Chemoradiotherapy on the Surgical Strategy According to the Clinical T Stage of Patients With Rectal Cancer. |
